Celina V Zerbinatti

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. pmc Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats
    Sokreine Suon
    Department of Neurosymptomatic Disorders, Merck Research Laboratories, West Point, PA 19486, USA
    Mol Neurodegener 5:44. 2010
  2. pmc Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein
    Celina V Zerbinatti
    Department of Pharmacology, Boston University School of Medicine, Boston, MA, 02118, USA
    Mol Neurodegener 3:5. 2008
  3. pmc PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain
    Mali Liu
    Neurology Department, Merck Research Laboratories, West Point, PA, USA
    J Lipid Res 51:2611-8. 2010

Collaborators

  • Mali Liu
  • Sokreine Suon
  • John J Renger
  • Stephanie A Villarreal
  • Ayesha Sitlani
  • George H Addona
  • Brian K Hubbard
  • Jie Zhao
  • Guoxin Wu
  • Kathleen K Bierilo
  • Michael Kavana
  • Timothy S Fisher
  • Linda M Carangia
  • John S Mudgett
  • Guillaume Pavlovic
  • Jennifer Baysarowich
  • Nikesh Anumula

Detail Information

Publications3

  1. pmc Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats
    Sokreine Suon
    Department of Neurosymptomatic Disorders, Merck Research Laboratories, West Point, PA 19486, USA
    Mol Neurodegener 5:44. 2010
    ..e., lipid poor apoE promotes Aβ aggregation/deposition while fully lipidated apoE favors Aβ degradation/clearance. In the brain, apoE levels and apoE lipidation are regulated by the liver X receptors (LXRs)...
  2. pmc Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein
    Celina V Zerbinatti
    Department of Pharmacology, Boston University School of Medicine, Boston, MA, 02118, USA
    Mol Neurodegener 3:5. 2008
    ....
  3. pmc PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain
    Mali Liu
    Neurology Department, Merck Research Laboratories, West Point, PA, USA
    J Lipid Res 51:2611-8. 2010
    ....